These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22123395)

  • 21. Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin.
    Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
    Mol Immunol; 2008 Feb; 45(4):910-24. PubMed ID: 17897717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.
    Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M
    J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
    Dolimbek BZ; Jankovic J; Atassi MZ
    Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates.
    Dolimbek BZ; Aoki KR; Atassi MZ
    Immunol Lett; 2011 Jun; 137(1-2):46-52. PubMed ID: 21324340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin.
    Ayyar BV; Tajhya RB; Beeton C; Atassi MZ
    Sci Rep; 2015 Oct; 5():15776. PubMed ID: 26508475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions.
    Atassi MZ
    Toxicon; 2015 Dec; 107(Pt A):50-8. PubMed ID: 26086358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain.
    Maruta T; Dolimbek BZ; Aoki KR; Steward LE; Atassi MZ
    Protein J; 2004 Nov; 23(8):539-52. PubMed ID: 15648976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin.
    Oshima M; Hayakari M; Middlebrook JL; Atassi MZ
    Mol Immunol; 1997 Oct; 34(14):1031-40. PubMed ID: 9488054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
    Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an Equine Antitoxin by Immunizing the Halla Horse with the Receptor-Binding Domain of Botulinum Neurotoxin Type A1.
    Kim NY; Park KE; Lee YJ; Kim YM; Hong SH; Son WR; Hong S; Lee S; Ahn HB; Yang J; Seo JP; Lim YK; Yu CH; Hur GH; Jeong ST; Lee HS; Song K; Kang TJ; Shin YK; Choi JS; Choi JY
    J Microbiol Biotechnol; 2019 Jul; 29(7):1165-1176. PubMed ID: 31280529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B).
    Shearer JD; Vassar ML; Swiderski W; Metcalfe K; Niemuth N; Henderson I
    Vaccine; 2010 Oct; 28(45):7313-8. PubMed ID: 20816903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins.
    Atassi MZ; Oshima M
    Crit Rev Immunol; 1999; 19(3):219-60. PubMed ID: 10422600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening of botulinum neurotoxin type A-binding peptides by phage display peptide library].
    Shi J; Wang H; Yin J; Hou XJ
    Wei Sheng Wu Xue Bao; 2006 Feb; 46(1):136-8. PubMed ID: 16579481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.
    Atassi MZ; Dolimbek BZ; Steward LE; Aoki KR
    Crit Rev Immunol; 2007; 27(4):319-41. PubMed ID: 18197812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
    Lipford GB; Hoffman M; Wagner H; Heeg K
    J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
    Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
    J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins.
    Kukreja R; Chang TW; Cai S; Lindo P; Riding S; Zhou Y; Ravichandran E; Singh BR
    Toxicon; 2009 May; 53(6):616-24. PubMed ID: 19673075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.
    Jun S; Clapp B; Zlotkowska D; Hoyt T; Holderness K; Maddaloni M; Pascual DW
    Int Immunol; 2012 Feb; 24(2):117-28. PubMed ID: 22207133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.